Literature DB >> 11113381

Susceptibility and resistance to Trypanosoma congolense infections.

H Tabel1, R S Kaushik, J E Uzonna.   

Abstract

We have put emphasis on recent findings in experimental Trypanosoma congolense infections in highly susceptible BALB/c and relatively resistant C57Bl/6 mice. Based on various analyses, it has been shown that a major difference in resistance to T. congolense infections is expressed early in infection at the macrophage level. A novel plastic-adherent Thy1.2(+) suppressor lymphocyte, which in absolute synergy with a Thy 1.2(-) cell exerts its suppression via interleukin-10 and interferon-gamma opens up an exciting new field of research.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11113381     DOI： 10.1016/s1286-4579(00)01318-6

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  19 in total

1.  Impaired Kupffer cells in highly susceptible mice infected with Trypanosoma congolense.

Authors:  Meiqing Shi; Guojian Wei; Wanling Pan; Henry Tabel
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Impact of primary mouse macrophage cell types on Leishmania infection and in vitro drug susceptibility.

Authors:  M Van den Kerkhof; L Van Bockstal; J F Gielis; P Delputte; P Cos; L Maes; Guy Caljon; Sarah Hendrickx
Journal:  Parasitol Res       Date:  2018-08-23       Impact factor: 2.289

3.  Trypanosoma congolense procyclins: unmasking cryptic major surface glycoproteins in procyclic forms.

Authors:  Silvia Utz; Isabel Roditi; Christina Kunz Renggli; Igor C Almeida; Alvaro Acosta-Serrano; Peter Bütikofer
Journal:  Eukaryot Cell       Date:  2006-08

4.  Clinical chemistry of congenic mice with quantitative trait loci for predicted responses to Trypanosoma congolense infection.

Authors:  Birgit Rathkolb; Harry A Noyes; Andy Brass; Paul Dark; Helmut Fuchs; Valérie Gailus-Durner; John Gibson; Martin Hrabé de Angelis; Moses Ogugo; Fuad Iraqi; Steve J Kemp; Jan Naessens; Mathew E Pope; Eckhard Wolf; Morris Agaba
Journal:  Infect Immun       Date:  2009-07-13       Impact factor: 3.441

5.  Distinct Contributions of CD4+ and CD8+ T Cells to Pathogenesis of Trypanosoma brucei Infection in the Context of Gamma Interferon and Interleukin-10.

Authors:  Gongguan Liu; Donglei Sun; Hui Wu; Mingshun Zhang; Haixia Huan; Jinjun Xu; Xiquan Zhang; Hong Zhou; Meiqing Shi
Journal:  Infect Immun       Date:  2015-04-27       Impact factor: 3.441

6.  Characterization of major surface protease homologues of Trypanosoma congolense.

Authors:  Veronica Marcoux; Guojian Wei; Henry Tabel; Harold J Bull
Journal:  J Biomed Biotechnol       Date:  2010-01-20

7.  Low-dose intradermal infection with trypanosoma congolense leads to expansion of regulatory T cells and enhanced susceptibility to reinfection.

Authors:  Chukwunonso Onyilagha; Ifeoma Okwor; Shiby Kuriakose; Rani Singh; Jude Uzonna
Journal:  Infect Immun       Date:  2013-12-16       Impact factor: 3.441

8.  Diminazene aceturate (Berenil) modulates the host cellular and inflammatory responses to Trypanosoma congolense infection.

Authors:  Shiby Kuriakose; Helen M Muleme; Chukwunonso Onyilagha; Rani Singh; Ping Jia; Jude E Uzonna
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

Review 9.  Human host determinants influencing the outcome of Trypanosoma brucei gambiense infections.

Authors:  B Bucheton; A MacLeod; V Jamonneau
Journal:  Parasite Immunol       Date:  2011-08       Impact factor: 2.280

10.  Trypanosoma congolense Infections: Induced Nitric Oxide Inhibits Parasite Growth In Vivo.

Authors:  Wenfa Lu; Guojian Wei; Wanling Pan; Henry Tabel
Journal:  J Parasitol Res       Date:  2011-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.